Growth Metrics

Quest Diagnostics (DGX) Short term Debt (2016 - 2025)

Historic Short term Debt for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $504.0 million.

  • Quest Diagnostics' Short term Debt fell 1641.79% to $504.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $504.0 million, marking a year-over-year decrease of 1641.79%. This contributed to the annual value of $602.0 million for FY2024, which is 9867.99% up from last year.
  • Latest data reveals that Quest Diagnostics reported Short term Debt of $504.0 million as of Q3 2025, which was down 1641.79% from $504.0 million recorded in Q2 2025.
  • Over the past 5 years, Quest Diagnostics' Short term Debt peaked at $906.0 million during Q1 2024, and registered a low of $1.0 million during Q3 2021.
  • For the 5-year period, Quest Diagnostics' Short term Debt averaged around $256.2 million, with its median value being $2.0 million (2021).
  • Its Short term Debt has fluctuated over the past 5 years, first soared by 4520000.0% in 2024, then crashed by 9988.96% in 2025.
  • Over the past 5 years, Quest Diagnostics' Short term Debt (Quarter) stood at $2.0 million in 2021, then changed by 0.0% to $2.0 million in 2022, then surged by 15050.0% to $303.0 million in 2023, then skyrocketed by 98.68% to $602.0 million in 2024, then decreased by 16.28% to $504.0 million in 2025.
  • Its Short term Debt was $504.0 million in Q3 2025, compared to $504.0 million in Q2 2025 and $1.0 million in Q1 2025.